Today: 30 April 2026
Browse Category

NASDAQ:ASND 9 December 2025

Ascendis Pharma (ASND) Stock Slides After Q3 Miss and FDA Delay – What Investors Need to Know on December 9, 2025

Ascendis Pharma (ASND) Stock Slides After Q3 Miss and FDA Delay – What Investors Need to Know on December 9, 2025

Ascendis Pharma shares fell 4.2% to around $197.25 in late trading December 9 after a Q3 earnings miss and a three-month FDA review delay for its key dwarfism drug. Volume was about 76% below average. The company posted Q3 revenue of €213.6 million but reported a net loss of €61 million, mainly from finance expenses. Despite the pullback, ASND remains near its 52-week high and up year-on-year.
9 December 2025
··

Stock Market Today

  • JPMorgan Active Value ETF (JAVA) Sees $314M Inflow, Key Holdings Mixed
    April 30, 2026, 11:12 AM EDT. The JPMorgan Active Value ETF (JAVA) experienced a notable $314.1 million inflow, marking a 5% increase in outstanding units week-over-week. JAVA currently trades near its 52-week high, last at $75.68 compared to a low of $61.46. Key underlying stocks showed mixed action: NXP Semiconductors (NXPI) slipped about 2%, while Charles Schwab (SCHW) and Walt Disney (DIS) rose 0.7% and 1% respectively. ETF unit creations indicate buying of underlying assets, influencing the prices of portfolio holdings. Monitoring these flows provides insight into investor demand and market momentum within ETFs.

Latest article

Mastercard Earnings Beat Wall Street, But April Cross-Border Slowdown Hits Stock

Mastercard Earnings Beat Wall Street, But April Cross-Border Slowdown Hits Stock

30 April 2026
Mastercard shares fell 2.7% Thursday despite first-quarter profit and revenue beating estimates, as investors reacted to slower April cross-border spending growth. Adjusted earnings reached $4.60 per share on $8.4 billion revenue. Cross-border volume growth dropped to 9% in April from 13% in Q1, with travel-linked growth at just 2%. Operating expenses rose 13%, including a $202 million restructuring charge.
Why Viavi Solutions Stock Is Surging After a Big Earnings Beat

Why Viavi Solutions Stock Is Surging After a Big Earnings Beat

30 April 2026
Viavi Solutions shares surged about 20% in early U.S. trading after fiscal third-quarter revenue rose 42.8% to $406.8 million, beating estimates. Adjusted earnings reached 27 cents per share, above forecasts. The company projected fourth-quarter revenue of $427 million to $437 million. GAAP profit declined from a year earlier and cash flow was negative for the quarter.
Go toTop